4
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001628280-22-003371
Options or other derivatives
- CEO acquired 240,448 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Fried Robert N CEO | 2022-02-17 | Grant or award · Employee Stock Options (right to buy) | +240,448 | 240,448 | D: show line 1 in the form |
Loading xslF345X03/wf-form4_164556891215777.xml…